Featured Job
-
Job Removed or Not Found
Related Jobs
- Daiichi Sankyo, Inc. (Bernards, NJ)
- Join a Legacy of Innovation 125 Years and Counting! Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve
- Eisai, Inc (NJ)
- …Develop and continually refine the medical strategy based on real-time insights, and provide critical medical input into the lifecycle management strategies. Lead the
- Novo Nordisk Inc. (WA)
- …JD or advanced degree required 8+ years of policy development, advocacy, legal, government affairs or other relevant experience required Expert knowledge of issues within
- Eisai, Inc (Nutley, NJ)
- …The Executive Director, Regulatory Affairs will provide leadership and direction for the global regulatory aspects of Eisai's products under development and post approval
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Requires a Bachelor's degree; Master's degree preferred 5+ years of experience including progressively responsible experience within sales, brand management/marketing
- Eisai, Inc (Nutley, NJ)
- …The Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL) is a field-facing representative of US Medical Affairs with a primary responsibility of
- Eisai, Inc (Philadelphia, PA)
- …Educational Requirements: Advanced terminal D degree in medical or health sciences (eg MD/DO, PhD, PharmD) Experience: 2-3 years MSL experience in neurology or complex
- Novo Nordisk Inc. (San Francisco, CA)
- …Doctoral degree required At least two years experience in a health-related system, pharmaceutical company, or managed care environment required Relevant clinical and/or
- Eisai, Inc (Bakersfield, CA)
- …Senior Medical Science Liaison Responsibilities: Act as the primary clinical/scientific resource to HCPs in the territory for information on disease state and Eisai's
- Novo Nordisk Inc. (Plainsboro, NJ)
- …This role also develops productive relationships and maintains contact with key account personnel, including C-suite executives and department heads. Additionally, this